2 Great Reasons to Buy This Cancer Treatment Stock Now

Six months into 2021, we are still experiencing a market of ups and downs. The S&P 500 is chugging along nicely with a 14% gain year to date, but stocks like Apple (NASDAQ: AAPL) and Amazon (NASDAQ: AMZN) -- both of which came out with mind-blowing revenue and earnings numbers earlier in the year -- have somehow failed to climb. In fact, as of this writing, Apple stock is down 1.9% on the year, while Amazon stock has had its moments but is currently sitting at only a 5% gain. Perhaps investors are looking for news on companies that will be life-changing, or even life-saving?

Clovis Oncology (NASDAQ: CLVS) may fit that bill. As a biotech aimed at improving and saving lives, Clovis is focused on advancing the fight against cancer with treatments for patients across the U.S., Europe, and internationally.

Image source: Getty Images.

Source Fool.com